$2.160
-0.191 (-8.86%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
OVID Prediction & Forecast by Similar Chart Analysis
Alphio's OVID stock price prediction model matches the current Ovid Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.18 (+0.78%). The 1-week path is $2.20 (+1.71%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ovid Therapeutics Inc Stock?
Ovid Therapeutics Inc is a good buy right now, trading at $2.16 with a forward P/E of 1.79, suggesting strong future earnings potential. The stock has a projected trajectory indicating a potential increase of 220.74%, supported by positive developments in their drug pipeline and a solid cash position of $165.6 million. However, the main risk is the high insider selling activity, which increased by 668.25% over the last quarter, indicating potential concerns from insiders about the company's future performance.
OVID stock price ended at $2.16 on Friday, after losing -8.86%
Ovid Therapeutics Inc (OVID) last closed at $2.16, losing -8.86%. These facts feed the 1-day and 1-week OVID price prediction above.
Analyst Consensus
Ovid Therapeutics Inc (OVID): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Ovid Therapeutics Inc (OVID) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches OVID, ranked by similarity.
Seasonality analysis for OVID
Historically the probability of a positive October return for OVID is 63.49%. September offers the highest probability of a positive month at 67.74%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for OVID
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $0.29 | $0.29 | $0.31 | -86.36% |
| Nov 2026 | $0.23 | $0.27 | $0.30 | -87.68% |
| Dec 2026 | $0.25 | $0.27 | $0.29 | -87.29% |
In 2026, Ovid Therapeutics Inc (OVID) is projected to range from $0.23 to $0.31.
Ovid Therapeutics Inc 2026 monthly forecast
In Oct 2026, Ovid Therapeutics Inc is projected to average $0.29, with a low of $0.29 and high of $0.31.
In Nov 2026, Ovid Therapeutics Inc is projected to average $0.27, with a low of $0.23 and high of $0.30.
In Dec 2026, Ovid Therapeutics Inc is projected to average $0.27, with a low of $0.25 and high of $0.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.